Institute
Our goal is to advance education and prevention, enhance patient treatment and rehabilitation, and work towards reducing the incidence of neurovascular diseases.
Today, scientific research, innovative technologies, and the dissemination of knowledge are the driving forces shaping the future. One of the greatest challenges of our time is to fully leverage these breakthroughs, ensuring that advanced applications become widely accessible to improve lives around the globe.
Founded in 2026, the Institute for Neurovascular Innovation is a scientific nonprofit organization committed to connecting specialized medical research with society. To this end, we act as a bridge and vital catalyst uniting research centers and clinical needs with volunteerism and resources provided by the business community.
Our goal is to advance education and prevention, enhance patient treatment and rehabilitation, and work towards reducing the incidence of neurovascular diseases.
Our work is structured around three key pillars:
Research & Innovation
Fostering scientific research through partnerships with universities and academic centers. We focus on developing innovative approaches to better understand neurovascular diseases, improve clinical prognosis, and enhance patient treatment and quality of life.
Prevention & Intervention
Designing and implementing public awareness, education, and expertise dissemination programs. We focus on prevention, early diagnosis, and reducing risk factors, mortality, and disability.
Rehabilitation & Integration
Modernizing public healthcare infrastructure and advancing neurological care by acting as a non-resource-handling catalyst between patients and those willing to offer support. We empower rehabilitation centers and healthcare professionals to deliver holistic patient care, expedite the reintegration process, and ensure a dignified quality of life.
The Institute is committed to filling critical gaps in medical education, focusing on systematic prevention, and inspiring volunteerism. We stand firmly by the families of patients on their long and arduous road to recovery, while championing scientific initiatives that foster informed and proactive communities.
The Institute is governed by the Assembly of Partners, whose resolutions are binding on all partners; the Executive Director, who is appointed for a three-year term to represent and bind the Institute before third parties; and the Scientific Council.
The Board is chaired by Ioannis Foteinos, Chairman of the BoD of the engineering and management consulting firm Salfo and Associates S.A. Board members are Sophia Foteinou, Kornilia Spirogianni, and Kyriaki Dervou.
